Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

2-Year Follow-Up: Expedited Versus Restrictive: Limitations on Activity Following Surgical Treatment of Prolapse (EVeRLAST)

NCT05542836 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT05542836
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05542836 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
2-Year Follow-Up: Expedited Versus Restrictive: Limitations on Activity Following Surgical Treatment of Prolapse (EVeRLAST)
Lead sponsor
Duke University
Phase
Observational
Overall status
Completed
Start date
September 30, 2022
Completion date
September 27, 2023
Enrollment
63 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pelvic organ prolapse